Pharmaceutical composition for treating cancer, containing mTOR-signaling inhibitor as active ingredient
Grant
US12582638B2
Kind: B2
Mar 24, 2026
Assignee
KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
Inventors
Seyun Kim, Boah Lee, Seung Ju Park
Abstract
The present invention relates to a pharmaceutical composition for preventing or treating cancer, containing a mTOR-signaling inhibitor as an active ingredient. The composition of the present invention exhibits the efficacy of inhibiting the growth of cancer cells and killing cancer cells, and thus can be used as an anticancer agent.
CPC Classifications
A61K 31/4468
Filing Date
2021-02-19
Application No.
17800627
Claims
9